The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet
FORMULA
1 other identifier
interventional
60
1 country
1
Brief Summary
It is hypothesized that the use of a partial supplement diet, which includes the use of meal replacements, will result in significantly greater weight loss after three and six months compared to an isocaloric diet that does not include supplements. It is also hypothesized that the partial supplement diet will result in larger improvements in body composition, disease biomarkers, and health parameters (blood pressure, lipids) compared to the non-supplement diet. Finally, it is hypothesized that subjective ratings of satiety will be significantly higher, and ratings of hunger lower, in the group consuming a partial supplement diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Apr 2005
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 29, 2005
CompletedFirst Posted
Study publicly available on registry
August 30, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2006
CompletedResults Posted
Study results publicly available
June 10, 2009
CompletedFebruary 8, 2016
January 1, 2016
1.1 years
August 29, 2005
April 21, 2009
January 15, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Body Weight Loss (kg and Percent) at Months 3 and 6
April 2005 to May 2006
Percent Change in Body Weight (Completers).
Percent change in body weight from baseline to week 24(completers).
24 weeks
Secondary Outcomes (3)
Change in Body Composition at Months 3 and 6
April 2005 to May 2006
Disease Biomarkers (Cholesterol, Triglycerides, Etc.) at Months 3 and 6
April 2005 to May 2006
Subjective Ratings of Appetite at Week 2 and Months 1, 2, 3, 4, 5, and 6
April 2005 to May 2006
Study Arms (2)
MicroDiet
EXPERIMENTALParticipants randomized to the MicroDiet group (1200 kcal/day) will be instructed by a Registered Dietitian to consume (one shake and 3 cookies; 240 kcal) for two meals each day for Months 1 through 3. They will be provided with meal plans for the meal that they do not replace with MicroDiet. During Months 4 through 6, participants in the MicroDiet group will be instructed to replace one meal per day with MD (the energy content of the meal plan will still be 1200 kcal/day). Participants will also be encouraged to eat or drink MD for snacks. The rest of the diet will consist of healthy foods, as outlined above. To help participants adhere to the MicroDiet regimen, they will meet with a registered dietitian for one hour at Week 0 and 30 minutes at Weeks 2 and 4, and every month thereafter.
Healthy Diet
ACTIVE COMPARATORParticipants randomized to the Healthy Diet group will be prescribed a traditional food-based diet that contains the same number of kilocalories (1200/day) as the MicroDiet. The Healthy Diet will consist of the same foods that are used in the meal plans for the MicroDiet group. The Healthy Diet group will be instructed not to use meal replacements such as shakes (e.g., Slim Fast®), nutrition bars (e.g., Balance Bar®), or portion-controlled meals (e.g., Healthy Choice entrees).
Interventions
Participants randomized to the Healthy Diet group will be prescribed a traditional food-based diet that contains the same number of kilocalories (1200/day) as the MicroDiet but will be instructed not to use meal replacements
Eligibility Criteria
You may qualify if:
- Male or female gender; of all ethnic backgrounds.
- Healthy person who has not been diagnosed with diabetes, cardiovascular illness, renal, hepatic or other chronic diseases
- \> 17 years and \< 66 years of age
- Body mass index (BMI; kg/m2) between 25 and 35
- For females with the potential to bear children, they meet one of the following criteria:
- They are willing to use an acceptable method of birth control (e.g., oral contraceptive tablets, implanted contraceptive hormones, Depo-Provera® contraceptive injections, intrauterine devices, prophylactic condoms with spermicide, contraceptive diaphragms with spermicide, cervical caps with spermicide), or are in a monogamous relationship with a partner who has had a vasectomy.
- They are sexually abstinent and intend to continue this practice, at least for the duration of the study.
You may not qualify if:
- \> 65 years and \< 18 years of age
- Regular use of medications other than birth control, vitamins or hormone replacement therapy
- Diabetes mellitus (fasting blood sugar \[FBS\] \> 126); persons with impaired glucose tolerance (FBS 100-125) may be admitted to the study.
- Use of tobacco products
- Depression or mental illness requiring treatment or medication within the last six months
- For women, pregnancy, breast feeding, postpartum \< 6 months, planning a pregnancy during the study, or are not using an acceptable method of contraception
- Use of medications or herbal supplements that affect appetite or body weight for the previous three months
- Patients requiring restriction of protein intake
- Impaired kidney function (creatinine \> 1.5) or liver function (liver enzymes \> 3 times the upper limits of normal)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pennington Biomedical Research Centerlead
- Sunny Health Co., Ltd.collaborator
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Corby K. Martin, Ph.D.; Assistant Professor
- Organization
- Pennington Biomedical Research Center
Study Officials
- PRINCIPAL INVESTIGATOR
Corby K. Martin, Ph.D.
Pennington Biomedical Research Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 29, 2005
First Posted
August 30, 2005
Study Start
April 1, 2005
Primary Completion
May 1, 2006
Study Completion
May 1, 2006
Last Updated
February 8, 2016
Results First Posted
June 10, 2009
Record last verified: 2016-01